Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00278889
Status:
COMPLETED
Last Update Posted:
2012-10-24
First Post:
2006-01-17
Brief Title:
Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic AcidLeucovorin F - Fluorouracil and OX - Oxaliplatin FOLFOX
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Organization Data
Organization:
AstraZeneca
Class:
INDUSTRY
Study ID:
D8480C00041
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AstraZeneca
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None